Acute Myeloid Leukemia

Disease State Hub

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

Featured

Expert Q&A
Kendall Diebold, DNP, FNP-C
Expert Q&A
Safety, Efficacy of 3-day Administration Schedule of Consolidation Cytarabine in Adults With AML
10/04/2024
Kendall Diebold, FNP-C, DNP, NP
Consolidation therapy with intermediate- to high-dose cytarabine is crucial in the prevention of acute myeloid leukemia relapse. In this Q&A, Kendall Diebold, DNP, FNP-C, answers questions...
10/04/2024
Conference Coverage
Conference Coverage
Conference Coverage
Long-Term Follow-Up Shows Continued Efficacy of Iomab B-Led Allogeneic Hematopoietic Cell Transplantation in Older Patients With Active, R/R AML
09/30/2024
Anthony Calabro, MA
In a long-term follow-up to SIERRA, a multicenter, randomized, controlled phase 3 study, researchers found that patients 55 years of age or older with active relapsed or refractory acute myeloid leukemia...
09/30/2024
Conference Coverage
conference coverage
Conference Coverage
Meta-Analysis: FLT3 Inhibitors vs Placebo for Patients With Acute Myeloid Leukemia
09/27/2024
Anthony Calabro, MA
Researchers who developed a meta-analysis of 19 randomized controlled trials found a statistically significant improvement in overall survival with sorafenib when compared with placebo for patients with...
09/27/2024

Interactive Features

Pop Quiz
pop quiz
Pop Quiz
Estimated Number of New Leukemia Diagnoses in 2024
02/27/2024
The American Cancer Society annually projects the number of new leukemia diagnoses in the United States. Which type of leukemia is projected to have the most diagnoses in 2024? Take the quiz to find out! ...
02/27/2024
Pop Quiz
pop quiz
Pop Quiz
FDA-Approved Quizartinib Targets Genetic Mutation Associated With AML
11/28/2023
Quizartinib is FDA-approved to treat patients with AML and which type of genetic mutation? Take this quiz to find out!
11/28/2023
pop quiz
quiz
pop quiz
Incidence of Acute Myeloid Leukemia
10/11/2023
Acute myeloid leukemia is one of the most common types of leukemia in adults, but what is the incidence of this type of leukemia among overall cases of cancer? Find out with this pop quiz.
10/11/2023
Pop Quiz
Pop Quiz
Pop Quiz
Genetic Mutations Associated With AML
08/29/2023
Do you know which genetic mutation is commonly associated with acute myeloid leukemia? Find out in our latest pop quiz!
08/29/2023
Pop Quiz
Kendall Diebold, DNP, FNP-C
Pop Quiz
Consolidation Cytarabine Administration in Adults With AML
08/10/2023
Do you know the primary purpose of consolidation cytarabine administration in the treatment of adults with acute myeloid leukemia, according to the poster discussion presented at ASCO 2023 titled "Outcomes...
08/10/2023

Clinical Insights

Expert Q&A
Kendall Diebold, DNP, FNP-C
Expert Q&A
Safety, Efficacy of 3-day Administration Schedule of Consolidation Cytarabine in Adults With AML
10/04/2024
Kendall Diebold, FNP-C, DNP, NP
Consolidation therapy with intermediate- to high-dose cytarabine is crucial in the prevention of acute myeloid leukemia relapse. In this Q&A, Kendall Diebold, DNP, FNP-C, answers questions...
10/04/2024
Video
headshot
Video
Microbiota Transplant Therapy Demonstrates Safety, Has No Effect on Infection for Patients with AML
05/10/2024
Alexander Khoruts, MD
In this video, Alexander Khoruts, MD, talks about his team's randomized, double-blind study, which showed that fecal microbiota transplant therapy is safe to use for patients with acute myeloid leukemia...
05/10/2024
Video
Ian Bouligny
Video
Venetoclax-based Strategies in Patients With Secondary-Type Mutations, Acute Myeloid Leukemia
12/08/2023
Ian Bouligny, MD
In this video, Ian Bouligny, MD, discusses his team’s research that aimed to determine the impact of secondary-type mutations in patients who were newly diagnosed with acute myeloid leukemia and treated...
12/08/2023
Conference Coverage
Kendall Diebold, DNP, FNP-C
Conference Coverage
Administration Schedule of Consolidation Cytarabine in Adults With Acute Myeloid Leukemia
11/21/2023
Kendall Diebold, FNP-C, DNP, NP
In this video, Kendall Diebold, DNP, FNP-C, speaks about her team’s research titled “Outcomes of 3- Versus 5-Day Administration Schedule of Consolidation Cytarabine in Adults with Acute Myeloid Leukemia,”...
11/21/2023
Expert Q&A
Ian Bouligny
Expert Q&A
Can Venetoclax-Based Strategies Be Used in Treating Patients With Secondary-Type AML Mutations?
10/30/2023
Ian Bouligny, MD
In this interview, Ian Bouligny, MD, answers questions about his team’s research that sought to determine the use of venetoclax-based strategies in patients with newly diagnosed secondary-type mutations of...
10/30/2023